Challenges and Future Opportunities for CAR-T
An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T A great interview of Dr. Michael Tees and Dr. Fred Locke by Arsalan Arif offering clinician views on current challenges and future opportunities for CAR-T (autologous + allogeneic). Link to video: https://carttogether.com Our takeaways? (1) There’s a move toward outpatient […]
Iovance Biotherapeutics Completes their BLA Submission for Lifileucel
An autologous tumor-infiltrating lymphocyte therapy for the treatment of advanced melanoma.
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced that they have executed a collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony Platform in the blood and hospital markets.
FDA Call for Submissions
Discussion Paper: Distributed Manufacturing and Point-of-Care Manufacturing of Drugs; Request for Information and Comments.